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INTRODUCTION:  Efﬁcacy  of daptomycin  has  been  recorded  in adult  Gram-positive  bone  and  joint  infec-
tions  OAI  (1)  and  daptomycin  has been  used  as  secondary  or  tertiary  agent  when  primary  agents  have
failed  (1,  2) in the  treatment  of  osteoarticular  infections  caused  by  Staphylococcus  aureus.
PRESENTATION OF  CASE:  We  report  a 16-year-old  schoolboy  with  Panton-Valentine  Leucocidin  (PVL)
positive  methicillin  susceptible  S. aureus  osteomyelitis,  who  was  refractory  to  9  days  of  recognised
antimicrobial  chemotherapy  with  progressive  multifocal  haematogenous  spread.  Subsequent  addition
of  daptomycin  promptly  cleared  the  bacteraemia  and  arrested  the  disease  process  within  9 days.
DISCUSSION:  Although  cases  have been  reported  of  daptomycin  usage  in  children  with  invasive  staphy-
lococcus  bacteraemia,  endocarditis  and  OAI (2),  we believe  this  to be  the  ﬁrst case  report  describing  theff  label drug use
aediatric
use  of  daptomycin  in paediatric  osteomyelitis  caused  by PVL  positive  S. aureus.
CONCLUSION: Repercussions  of  osteomyelitis,  in  particular  those  caused  by PVL  S.  aureus,  and  evolving
resistance  patterns  internationally,  highlight  the  need  for  further  evaluation  of  daptomycin  in the  paedi-
atric  arena.  The  response  seen  with  the addition  of  Daptomycin  in  this  case  suggests  possible  reduction
in  hospital  stay  and  number  of  surgical  procedures  when  compared  to other  published  series  using
conventional  antibiotic  regimens.
gical © 2012 Sur
. Introduction
PVL is an exotoxin that destroys leukocytes by creating pores
n cell membranes. Genes encoding PVL are present in less than
% of community-acquired methicillin-susceptible Staphylococcus
ureus (CA-MSSA) in Europe,3–5 though signiﬁcant geographic vari-
tions exist.
PVL  positive S. aureus infection has a broad presentation proﬁle
nd has been reported in a number of young people with a history
f contact sports.6 The condition may  start with relatively non-
peciﬁc symptoms and include skin lesions3 and deep abscesses7
ut can include necrotizing pneumonia3 and complicated mus-
uloskeletal infection.8,9 Sepsis related multi-organ failure and/or
ecrotising pneumonia account for the high fatality rates observed3
nd the requirement of intensive care facilities. Greater severity of
nfection is seen when compared with a PVL negative infection.6,10Daptomycin binds to bacterial membranes in a calcium-
ependent manner, causing subsequent potassium efﬂux. This
eads to arrest of several intracellular processes, including
Abbreviations: PVL, Panton-Valentine Leucocidin; MSSA, methicillin-sensitive
taphylococcus aureus; OAI, Osteoarticular infection.
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Deoxyribonucleic acid and Ribonucleic acid production and pro-
tein synthesis, thereby hampering PVL production. This cascade
eventually leads to bacterial death.11 Daptomycin’s efﬁcacy has
been demonstrated in animal models12,13 with eradication of
blood born and osteoarthritic infections with antibiotic-resistant
and antibiotic-sensitive Gram-positive bacteria.1 Efﬁcacy has been
recorded in adult Gram-positive bone infections14 and it has been
used in adults as a secondary or tertiary agent when primary agents
have failed.1
Health Protection Agency guidelines15 for treatment of PVL-
induced skin and soft tissue infections in children recommend
ﬂucloxacillin, clindamycin, linezolid. In adults with osteomyelitis
or other deep seated infections, daptomycin is recommended as
a second-line agent.15 Daptomycin, can be considered in therapy-
refractory PVL-positive staphylococcal infections in children and
we present such a case.
2.  Presentation of case
A previously well 16-year-old boy presented with a 3-day his-
Open access under CC BY-NC-ND license.tory of rigors, vomiting, diarrhoea and 2-day history of lethargy,
loss of appetite and worsening pain of his right knee. He had played
football 2 days prior to onset of symptoms, but had no history of
trauma.
 BY-NC-ND license.
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in the management of osteomyelitis is limited. A 2001 meta-
analysis concluded that little high-quality evidence-based therapy
for osteomyelitis and septic arthritis exists.16 An open-label ran-
domized control trial of standard treatment with vancomycinCASE  REPORT
G. Erturan et al. / International Journa
On examination he was pyrexial, tachycardic and tachypnoeic.
here was a mild effusion of the right knee. He was able to perform
 straight-leg raise, but had pain on ﬂexion and weight-bearing.
he right hip and contralateral lower limb were unremarkable. Ini-
ial investigations included normal chest radiograph, white blood
ount (WBC) of 6.24 × 109/mm3, platelets 115 × 109/L, erythrocyte
edimentation rate of 74, C-reactive protein (CRP) of 302.4 mg/L
nd normal chemistry. The right knee aspirate demonstrated no
rganisms or crystals. Clinical impression was of a viral illness, pos-
ibly gastroenteritis, with reactive arthritis and he was treated with
nti-inﬂammatories.
On Day 2 he remained pyrexial with increasing right knee pain.
epeat examination showed venous prominence on the medial
spect and effusion with tenderness around the right knee, but
peciﬁcally in the popliteal fossa. Joint aspirate from admission
emained culture negative and therefore the knee was re-aspirated.
nitial blood cultures from admission grew methicillin-susceptible
. aureus and, following discussion with local microbiology, he was
ommenced on intravenous ﬂucloxacillin (2 g four times daily) and
ral clindamycin (300 mg  four times daily). An urgent arthroscopic
ashout did not show evidence of synovitis.
On day 4 he developed coughing and an oxygen requirement.
e was tachycardic, tachypnoeic and hypotensive. WBC  rose to
2.61 ×109/mm3, platelets of 148 × 109/mm3 and CRP 185.2 mg/L.
On Day 8 with increasing right knee pain and associated oedema,
agnetic resonance imaging (MRI) (Fig. 1) conﬁrmed right proxi-
al tibial osteomyelitis. He underwent incision and drainage of
he right proximal tibia. Subperiosteal pus was drained and cortex
indowed to release intramedullary pus.
Other symptoms included right-sided chest pain, worsening dry
ough and vomiting. Bilateral chest crepitations on examination
nd chest radiograph with right upper lobe shadowing prompted
omputed tomography that showed cavitating lung lesions in
eeping with a diagnosis of multi-lobar pneumonia. Transthoracic
chocardiogram revealed pericardial effusion, but without evi-
ence of intravascular infection. Given the adequate views attained,
he Cardiology consultant did not think a trans-oesophageal echo
ould be additionally instructive.
On day 9 his clinical condition deteriorated and he was
ntubated, ventilated and transferred to Paediatric Intensive
ig. 1. Magnetic resonance imaging demonstrating osteomyelitc change in the right
roximal tibia and left distal tibia.PEN  ACCESS
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Care. Samples were sent to the reference laboratory because of
suspicion of PVL septicaemia, and contact isolation of the patient
and screening of close family members was commenced. Intra-
venous ﬂucloxacillin was  discontinued and intravenous linezolid
(600 mg twice daily) was  commenced.
Second washout and debridement of right proximal tibia and
primary drainage of left distal tibia were performed. All 8 specimens
taken and repeat blood cultures were culture positive for S. aureus.
Despite further surgical debridement and double antibiotic
therapy, his CRP continued to rise (227 mg/L), with no clinical
improvement and so on day 11 intravenous daptomycin at 8 mg/kg
was added to linezolid and clindamycin. The isolate was  conﬁrmed
as PVL-positive on day 13.
His clinical condition improved, his chest cleared and by day
20 a repeat echocardiograph showed the pericardial effusion had
resolved and CRP was  14.8 mg/L. Continued left ankle symptoms
triggered a further MRI  of distal tibia and it’s subsequent debride-
ment. All specimens including repeat blood cultures were culture
negative. A radioisotope bone scan excluded silent multifocal dis-
ease (Fig. 2).
With  subjective and objective improvement he was discharged
home on day 30 with oral clindamycin and by day 44 his left ankle
wound had completely healed, while his right tibial wound had
decreased in size and CRP was 1.8 mg/L. At 1 year the left ankle was
asymptomatic with full range of movement, right tibia was pain-
free but the proximal growth plate had fused leaving 1 cm leg length
discrepancy at skeletal maturity. No further episodes of infection
have taken place.
3.  Discussion
Data on effectiveness of antibiotic therapy and optimal durationFig. 2. Isotope bone scan demonstrating hot spots at right proximal tibia and left
ankle.
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Table  1
Comparison of our case to another paediatric published case report and two series of children with PVL S. aureus osteoarticular infections managed with standard regimens.
Number of cases Median length of
stay  (days)
Median Surgical
procedures
Number with
long-term
morbidity
Number of
fatalities
Series 1 9 14 45 (10–90) 2 (0–5) 12 0
Series  2 6 11 51 (14–255) 5 (1–11) 5 1
Case  report 19 1 50 3 0 0
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ersus daptomycin in adults with osteoarticular infections sec-
ndary to staphylococcal infection, suggested daptomycin may  be
onsidered an alternative to standard therapy.14
Published use of daptomycin in paediatric infections are also
imited and focus mainly on invasive staphylococcal disease of soft
issues. Addition of daptomycin has been reported in both adults
nd children and resulted in bacteriologic cure following a previ-
usly persistent bacteraemia in adults17 and children2 secondary to
nfection with Gram-positive-cocci. However, none of these reports
ook speciﬁcally at PVL positive S. aureus infection.
As in the case described, PVL-positive infections may  be non-
peciﬁc on presentation, but in the presence of joint pain with a
egative aspirate one must consider osteomyelitis and perform MRI
arly. An earlier MRI  is likely to have been helpful in this child’s
ase. If the clinical picture is progressive despite treatment, follow-
p blood cultures at 48 h should be taken. A persistent bacteraemia
epresented biochemically by sharp secondary rise in inﬂammatory
arkers, was our trigger for alternative and/or additional therapy.
n the light of the severely deteriorating clinical picture, and in spite
f the relative contraindication of pneumonia,18 we  had to consider
ther pharmaceutical options regardless of Level 1 evidence.
Our  institution attempts to apply a protocol to trigger early lab-
ratory referral for PVL. In positive cases managed in our hospital
he inﬂammatory cascade is so marked and prolonged that despite
 resolving bacteraemia indicated by falling inﬂammatory mark-
rs, one frequently witnesses sporadic pyrexia. Isolated pyrexial
anifestations should not be used as the sole reason to change anti-
icrobial therapy, neither should they be thought of as secondary
o drug side effects, without supplementary evidence.
Table 1 shows a comparison of our case of PVL positive paediatric
steomyelitis treated with dapatomycin, another published case
eport and two series of children with PVL S. aureus osteoarticular
nfections managed with standard regimens.
. Conclusion
Rapid bactericidal activity against growing and stationary-
hase bacteria, a once-daily dosing regimen, and no requirement
or drug monitoring contribute to daptomycin’s potential ther-
peutic utility.2 Although licensed only for treatment of com-
licated skin and soft-tissue infections in adults, with activity
gainst a range of aerobic and anaerobic Gram-positive bacteria
ncluding methicillin-resistant S. aureus and MSSA, glycopeptide-
ntermediate S. aureus, methicillin-resistant coagulase-negative
taphylococcus spp, and vancomycin-resistant enterococci, its suc-
ess, albeit as an adjucnt to clindamycin and linezolid in this case,
hows that further research is necessary to assess its true role in
he management of paediatric osteomyelitis.onﬂict of interest
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